612 related articles for article (PubMed ID: 34543382)
1. Heparin-induced thrombocytopenia in patients with COVID-19: a systematic review and meta-analysis.
Uaprasert N; Tangcheewinsirikul N; Rojnuckarin P; Patell R; Zwicker JI; Chiasakul T
Blood Adv; 2021 Nov; 5(21):4521-4534. PubMed ID: 34543382
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19.
Lerner RK; Lotan D; Oren D; Itelman E; Neeman Y; Dekel S; Heller E; Abu-Much A; Shilo N; Gilead R; Hubara E; Mouallem M; Haviv Y; Kogan A; Mayan H; Pessach IM
Clin Med (Lond); 2022 Sep; 22(5):403-408. PubMed ID: 36507809
[TBL] [Abstract][Full Text] [Related]
3. How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?
Levine RL; McCollum D; Hursting MJ
Chest; 2006 Sep; 130(3):681-7. PubMed ID: 16963663
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies.
Pilia E; Belletti A; Fresilli S; Lee TC; Zangrillo A; Finco G; Landoni G;
Lung; 2023 Apr; 201(2):135-147. PubMed ID: 36738324
[TBL] [Abstract][Full Text] [Related]
5. Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review.
Bloemen A; Testroote MJ; Janssen-Heijnen ML; Janzing HM
Injury; 2012 May; 43(5):548-52. PubMed ID: 21640991
[TBL] [Abstract][Full Text] [Related]
6. Heparin-Induced Thrombocytopenia in COVID-19.
Lingamaneni P; Gonakoti S; Moturi K; Vohra I; Zia M
J Investig Med High Impact Case Rep; 2020; 8():2324709620944091. PubMed ID: 32720827
[TBL] [Abstract][Full Text] [Related]
7. Significance of heparin induced thrombocytopenia (HIT) in COVID-19: a systematic review and meta-analysis.
Rostami M; Mansouritorghabeh H
J Thromb Thrombolysis; 2023 Aug; 56(2):241-252. PubMed ID: 37219826
[TBL] [Abstract][Full Text] [Related]
8. Cerebral Venous Thrombosis in Patients With Heparin-Induced Thrombocytopenia a Systematic Review.
Aguiar de Sousa D; Romoli M; Sánchez Van Kammen M; Heldner MR; Zini A; Coutinho JM; Arnold M; Ferro JM
Stroke; 2022 Jun; 53(6):1892-1903. PubMed ID: 35240862
[TBL] [Abstract][Full Text] [Related]
9. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
Junqueira DR; Perini E; Penholati RR; Carvalho MG
Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and outcomes of heparin-induced thrombocytopenia in hospitalized patients with venous thromboembolic disease: Insight from national inpatient sample.
Shah NB; Sharedalal P; Shafi I; Tang A; Zhao H; Lakhter V; Kolluri R; Rao AK; Bashir R
J Vasc Surg Venous Lymphat Disord; 2023 Jul; 11(4):723-730. PubMed ID: 36893884
[TBL] [Abstract][Full Text] [Related]
11. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.
Girolami B; Prandoni P; Stefani PM; Tanduo C; Sabbion P; Eichler P; Ramon R; Baggio G; Fabris F; Girolami A
Blood; 2003 Apr; 101(8):2955-9. PubMed ID: 12480713
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prophylactic anticoagulation, deep venous thrombosis, and heparin-induced thrombocytopenia in 21 burn centers in Germany, Austria, and Switzerland.
Busche MN; Herold C; Krämer R; Knobloch K; Vogt PM; Rennekampff HO
Ann Plast Surg; 2011 Jul; 67(1):17-24. PubMed ID: 21629067
[TBL] [Abstract][Full Text] [Related]
13. Systematic review on heparin-induced thrombocytopenia in children: a call to action.
Avila ML; Shah V; Brandão LR
J Thromb Haemost; 2013 Apr; 11(4):660-9. PubMed ID: 23350790
[TBL] [Abstract][Full Text] [Related]
14. Frequency of heparin-induced thrombocytopenia in critical care patients.
Verma AK; Levine M; Shalansky SJ; Carter CJ; Kelton JG
Pharmacotherapy; 2003 Jun; 23(6):745-53. PubMed ID: 12820817
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management.
Hogan M; Berger JS
Vasc Med; 2020 Apr; 25(2):160-173. PubMed ID: 32195628
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.
Crowther M; Cook D; Guyatt G; Zytaruk N; McDonald E; Williamson D; Albert M; Dodek P; Finfer S; Vallance S; Heels-Ansdell D; McIntyre L; Mehta S; Lamontagne F; Muscedere J; Jacka M; Lesur O; Kutsiogiannis J; Friedrich J; Klinger JR; Qushmaq I; Burry L; Khwaja K; Sheppard JA; Warkentin TE; ; ;
J Crit Care; 2014 Jun; 29(3):470.e7-15. PubMed ID: 24726205
[TBL] [Abstract][Full Text] [Related]
17. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
18. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study.
Gettings EM; Brush KA; Van Cott EM; Hurford WE
Crit Care; 2006; 10(6):R161. PubMed ID: 17109753
[TBL] [Abstract][Full Text] [Related]
19. Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?
Zhou A; Winkler A; Emamifar A; Gartland B; Duncan A; Antun A; Arellano M; Tindol GA; Levy JH; Bornstein WA; Horowitz IR; Khoury HJ
Chest; 2012 Nov; 142(5):1175-1178. PubMed ID: 22539642
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
